KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Long-Term Investments (2020 - 2025)

Historic Long-Term Investments for Charles River Laboratories International (CRL) over the last 8 years, with Q3 2025 value amounting to $194.6 million.

  • Charles River Laboratories International's Long-Term Investments rose 5454.09% to $194.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $194.6 million, marking a year-over-year increase of 5454.09%. This contributed to the annual value of $218.4 million for FY2024, which is 1044.29% down from last year.
  • According to the latest figures from Q3 2025, Charles River Laboratories International's Long-Term Investments is $194.6 million, which was up 5454.09% from $216.1 million recorded in Q2 2025.
  • Charles River Laboratories International's Long-Term Investments' 5-year high stood at $311.6 million during Q4 2022, with a 5-year trough of $60.6 million in Q1 2022.
  • For the 5-year period, Charles River Laboratories International's Long-Term Investments averaged around $200.8 million, with its median value being $207.7 million (2021).
  • Per our database at Business Quant, Charles River Laboratories International's Long-Term Investments skyrocketed by 71505.83% in 2021 and then tumbled by 6044.31% in 2024.
  • Charles River Laboratories International's Long-Term Investments (Quarter) stood at $201.4 million in 2021, then soared by 54.75% to $311.6 million in 2022, then fell by 21.76% to $243.8 million in 2023, then dropped by 10.44% to $218.4 million in 2024, then decreased by 10.86% to $194.6 million in 2025.
  • Its Long-Term Investments was $194.6 million in Q3 2025, compared to $216.1 million in Q2 2025 and $214.0 million in Q1 2025.